Navigation Links
Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces
Date:10/13/2009

an.com" onclick="linkClick( this.href );" target="_blank" title="OxiTitan VLR">OxiTitan VLR is a proprietary nanoscale zinc/titanium dioxide sol that can be easily applied to a wide variety of surfaces and textiles. The EcoActive Surfaces cleantech innovation provides a virtually invisible, durable coating with broad spectrum antimicrobial effects based on strong initial binding and subsequent photocatalysed oxidative inactivation under ordinary interior lighting conditions. The transparent coating creates free oxygen radicals that chemically inactivate essential components of viruses and bacteria to kill them, and also destroy volatile organic compounds. Powered only by the energy of visible light, OxiTitan VLR contains tiny particles of the same minerals used in the safest sunscreens, has no poisons or toxins, and is benign in the environment.

"In today's world, where dangerous viruses and bacteria may be spread by contact with surfaces in our human environment, it is important that consumers know that a persistent, safe, and continuously active antimicrobial coating is now available for interior use on existing surfaces in a multitude of environments, including healthcare facilities, community buildings such as schools, as well as residences and businesses. OxiTitan VLR acts as 'a vigilant sentry', reducing microbial contamination all day, every day, and between routine surface cleaning," stated Dr. Averett.

OxiTitan VLR provides a safe, durable, cost-effective, ecologically friendly, and continuously active antimicrobial surface clear-coating. When used as an adjunct to hand hygiene and normal cleaning, OxiTitan VLR provides an important and long-lasting component in the battle to reduce the spread of pathogens and break the nosocomial infection loop.

Although the materials science behind OxiTitan VLR is advanced and complex, its application is simple. The pre-mixed, water based formula is simply sprayed
'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Connectyx Technologies Retained the Marcum Group in New York as its Independent Registered Public Accountant for the Purpose of Becoming a Fully Reporting Company
2. RCRC Independent Review Board Announces DHHS Research Oversight
3. URAC Open Public Comment Period for New Independent Review Organization Standards
4. GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care
5. Gentiva(R) Health Services Announces Appointment of Three Independent Directors
6. 2 Independent Studies Released on the Effectiveness of Prostate Cancer Treatment
7. Independent Analysis Shows Granite Countertops Pose No Health Risk
8. BioNeutrals Ygiene(TM) Achieves Worlds Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicidal/Sterilant Test
9. China Medical Technologies Announces Change of Independent Auditors
10. Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show
11. China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 
Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces
(Date:11/22/2009)...-USNewswire/ -- Congressman Chaka Fattah (D-PA) is...s Senate,s vote tonight to proceed to debate on Af...Arlen Specter and Bob Casey deserve the thanks of ...stand-up, critical votes in the Senate tonight adv...h Care Reform legislation to full debate. The Pres...
(Date:11/21/2009).../ -- Milvia Lopez, by her attorney MICHAEL STEWART...n Supreme Court, New York County, bearing Index # ...Lopez underwent a routine transesophageal echocard...s used an HIV infected scope exposing her to HIV. ...fter being discharged from the procedure and arriv...
(Date:11/21/2009)...l credentialing software company IntelliSoft Group...p with Amerinet, Inc., the leading healthcare G.P....sform quality care within the healthcare market. ...9 -- ISG Group, LLC, doing business as IntelliSoft...t Inc., a leading national healthcare group purcha...
(Date:11/21/2009)...l Group merges their practice with that of E. Stev... (PRWEB) November 21, 2009 -- The New H... Gibson, Dr. Dean Cloutier, Dr. John Plachtyna and...g practice with that of esteemed colleague Dr. E. ...nted to retire from dentistry in order to concentr...
(Date:11/20/2009)...ire-USNewswire/ -- The American Academy of Actuar...form legislation released this week to contain str...dual coverage mandate. The actuaries said that an ...verse selection stemming from more restrictive iss..."The individual mandate language should be strengt...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2
...ene Therapeutics Research Institute at Cedars-Sina...t it is possible to sustain therapeutic gene expre...ar, even in the presence of an anti-viral immune r...vel gutted adenoviral vector called HC-Adv, is com...
...rm outcomes, researchers say , THURSDAY, Oct. 25 (...rial natriuretic peptide (ANP) can lessen cardiac ...omes, a new study finds. , According to a Japanese...usion injuries," caused when blood rushes back to ...
...compare more than 500 health pla...26 U.S.News & World Report and the,National Commi...he third,edition of America,s Best Health Plans, a...families face health plan,selection options, the r...
...k Engineer and Information, Technology Magazines ..., ABBOTT PARK, Ill., Oct. 26 Abbott (NYSE: ABT ... diversity in two publications.,Abbott was named a...rsity in the magazine. In addition, Abbott was,nam...
...lth Plans, Lists for Third ...e third consecutive year,HealthPlus of Michigan,s ...,plans have been recognized by U.S. News & World R...are and Medicaid in the,national news magazine,s U...
...and,House Democratic leaders held a news conferenc...n the revised bipartisan SCHIP bill, which passed ...pening remarks:, "Today we took another step forw...ation where on the motion to recommit,the Republic...
Other Medicine News:Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 2Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 3Health News:Abbott Again Honored as a Leader in Diversity 2Health News:Abbott Again Honored as a Leader in Diversity 3
(Date:11/20/2009)...ov. 20 Soligenix, Inc. (...y), formerly known as DOR BioPharma, Inc., a late-...it has formed a consortium to develop thermostable... acting vaccines. Soligenix received a $9.4 millio... Infectious Diseases (NIAID), a division of the Na...
(Date:11/19/2009)...Nov. 19 BioCryst Pharmac...e pricing of a public offering of 5,000,000 shares... in gross proceeds of $48.75 million. All of the ...n effective shelf registration statement previousl...n. BioCryst has also granted the underwriters a 3...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3OPAXIO 28TM 29 Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annu 5050 1Open innovation networks are one key to improved care 58222 1Open innovation networks are one key to improved care 58222 2Open innovation networks are one key to improved care 58222 3Open innovation networks are one key to improved care 58222 4Open innovation networks are one key to improved care 58222 5Fish fend off invading germs with an initial response similar to the one found in people 10082 1Fish fend off invading germs with an initial response similar to the one found in people 10082 2
... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), ...oday announced that it will present updated result...one-year survival data, during a,poster discussion...Study of,Lung Cancer,s (IASLC) 12th World Conferen... Poster number: PD6-1-1 Title: A phase 2 study o...
... (Nasdaq:,VICL) announced today that results from ...using a plasmid DNA (pDNA) vaccine developed by th...Vical, reinforced previously,reported Phase 1 conc...,vaccine regimen was safe and well-tolerated, and ...in up to 70% of the vaccine recipients. "These re...
Other Medicine Technology:Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 2Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 3Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: